マーケットレポート詳細
血漿分画製剤の世界市場：2027年に至る製剤別、用途別予測
Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) - Global Forecast to 2027
- 出版元：MarketsandMarkets
出版元について - 発行年：2022年5月
- 定価 ：Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文330ページになります。
- 商品コード：MAM2930
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
血漿分画製剤の世界市場規模は2022年で265億ドル、2027年に367億ドル、市場の平均年成長率は6.7%に達すると予測されています。
レポートは血漿分画製剤の世界市場について2027年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（製品別市場、用途別市場、等 ）を中心に構成されています。また競合状況、主要企業情報（15社）、市場ダイナミクス、市場シェア分析、競合状況などの分析も加味し、血漿分画製剤市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆血漿分画製剤の世界市場予測2020-2027年
・市場規模(US$)
◆製品別、市場-2027年
免疫グロブリン
・静注用免疫グロブリン
・皮下注用免疫グロブリン
・その他免疫グロブリン
凝固因子濃縮製剤
・第VIII因子
・第IX因子
・フォンウィルブランド因子
・プロトロンビン複合体製剤
・フィブリノゲン濃縮製剤
・第XIII因子
・第XI因子
アルブミン
プロテアーゼ阻害剤
その他血漿製品
※(市場規模US$)
◆用途別、市場-2027年
・神経学
・免疫学
・血液学
・救命救急
・呼吸器科
・血液腫瘍学
・リウマチ
・その他用途
※(市場規模US$)
◆エンドユーザー別、市場-2027年
・病院/クリニック
・臨床研究所
・学術機関
※(市場規模US$)
◆主要国地域別市場-2027年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、オーストラリア、インド
・ベトナム、インドネシア、マレーシア
・その他アジア太平洋
中南米
・ブラジル、その他中南米
中東アフリカ
・トルコ、サウジアラビア
・エジプト、UAE
・その他中東アフリカ
※国地域別に全セグメントの細分化データ掲載、詳細は目次参照
◆市場分析
・市場ダイナミクス(ドライバー、障壁、機会、課題)
・価格分析
・COVID-19の影響
・バリューチェーン分析
・サプライチェーン分析
・エコシステム分析
・特許分析
・規制分析
・ファイブフォース分析
・技術分析
・市場シェア分析
・競合状況
◆血漿分画製剤の主要企業プロフィール動向
・CSL
・GRIFOLS, S.A.
・SHIRE (TAKEDA PHARMACEUTICAL COMPANY LIMITED)
・OCTAPHARMA AG
・KEDRION S.P.A
・LFB
・BIOTEST AG
・SANQUIN
・CHINA BIOLOGIC PRODUCTS HOLDINGS, INC.
・GC PHARMA
・BIO PRODUCTS LABORATORY LTD.
・一般社団法人 日本血液製剤機構
・EMERGENT BIOSOLUTIONS
・SHANGHAI RAAS BLOOD PRODUCTS CO., LTD.
・INTAS PHARMACEUTICALS LTD.
(その他企業）
・BHARAT SERUMS AND VACCINES LIMITED
・SK PLASMA
・SICHUAN YUANDA SHUYANG PHARMACEUTICAL CO., LTD.
・KABAFUSION
・CENTURION PHARMA
・ADMA BIOLOGICS, INC.
・PLASMAGEN BIOSCIENCES PVT. LTD.
・VIRCHOW BIOTECH PRIVATE LIMITED
・FUSION HEALTHCARE
・HEMARUS THERAPEUTICS LIMITED
（全330頁）
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1.... INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
・ FIGURE 1............................... PLASMA FRACTIONATION MARKET
1.3.1 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2.... RESEARCH METHODOLOGY
2.1 RESEARCH DATA
・ FIGURE 2.................................................. RESEARCH DESIGN.. 33
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
・ FIGURE 3............... BREAKDOWN OF PRIMARIES BY RESPONDENT, DESIGNATION, AND REGION: PLASMA FRACTIONATION MARKET
2.2 MARKET ESTIMATION METHODOLOGY
・ FIGURE 4......... PLASMA FRACTIONATION MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2021
・ FIGURE 5........ MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2021
2.2.1 INSIGHTS FROM PRIMARY EXPERTS
・ FIGURE 6........ MARKET SIZE VALIDATION FROM PRIMARY SOURCES
2.3 MARKET GROWTH RATE PROJECTIONS
・ FIGURE 7... PLASMA FRACTIONATION MARKET (SUPPLY SIDE): CAGR PROJECTIONS
・ FIGURE 8.......... PLASMA FRACTIONATION MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS
2.3.1 DATA TRIANGULATION
・ FIGURE 9.......................... DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH ASSUMPTIONS
2.4.1 COVID-19 ASSUMPTIONS
2.5 RISK ANALYSIS
3.... EXECUTIVE SUMMARY
・ FIGURE 10........... PLASMA FRACTIONATION MARKET, BY PRODUCT,
2022 VS. 2027 (USD MILLION)
・ FIGURE 11...... PLASMA FRACTIONATION MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION)
・ FIGURE 12.......... PLASMA FRACTIONATION MARKET, BY END USER,
2022 VS. 2027 (USD MILLION)
・ FIGURE 13................. GEOGRAPHICAL SNAPSHOT OF THE PLASMA FRACTIONATION MARKET
4.... PREMIUM INSIGHTS
4.1 PLASMA FRACTIONATION MARKET OVERVIEW
・ FIGURE 14....... GROWING USE OF IMMUNOGLOBULINS IN VARIOUS THERAPEUTIC AREAS IS THE MAJOR FACTOR DRIVING MARKET GROWTH
4.2 NORTH AMERICA: PLASMA FRACTIONATION MARKET, BY PRODUCT & COUNTRY (2019)
・ FIGURE 15...... IMMUNOGLOBULINS ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN PLASMA FRACTIONATION MARKET IN 2021
4.3 PLASMA FRACTIONATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
・ FIGURE 16......... GERMANY TO REGISTER THE HIGHEST CAGR IN THE PLASMA FRACTIONATION MARKET DURING THE FORECAST PERIOD
5.... MARKET OVERVIEW
5.1 INTRODUCTION
5.1.1 MARKET DYNAMICS.. 50
・ FIGURE 17................ PLASMA FRACTIONATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2 MARKET DYNAMICS
・ TABLE 1......... PLASMA FRACTIONATION MARKET: IMPACT ANALYSIS
5.2.1 MARKET DRIVERS
5.2.1.1 GROWING USE OF IMMUNOGLOBULINS IN VARIOUS THERAPEUTIC AREAS
・ TABLE 2................ ON-LABEL AND OFF-LABEL INDICATIONS OF IVIG
・ TABLE 3 NUMBER OF CLINICAL STUDIES ON IMMUNOGLOBULINS, BY REGION
(AS OF 2020–2021)
・ TABLE 4.......... NUMBER OF PATIENTS TREATED FOR TOP 15 TARGET CONDITIONS IN THE UK
5.2.1.2 RAPIDLY GROWING GERIATRIC POPULATION
・ TABLE 5............. GERIATRIC POPULATION, BY REGION, 2000−2050
5.2.1.3 GROWING PREVALENCE OF RESPIRATORY DISEASES AND AATD
5.2.1.4 NEW INDICATIONS FOR PLASMA PRODUCTS
5.2.2 MARKET RESTRAINTS.. 56
5.2.2.1 HIGH COSTS AND LIMITED REIMBURSEMENTS
5.2.2.2 MARKET DISRUPTION CAUSED BY RECOMBINANT ALTERNATIVES
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 INCREASED RISK OF COMMUNICABLE DISEASES
5.2.3.2 RISING PREVALENCE OF BLEEDING DISORDERS
・ FIGURE 18 NUMBER OF HEMOPHILIA A AND HEMOPHILIA B PATIENTS WORLDWIDE, 2012–2018
・ TABLE 6...... NUMBER OF HEMOPHILIA PATIENTS IN DEVELOPED AND EMERGING COUNTRIES, 2016 VS. 2018
5.2.4 MARKET CHALLENGES.. 58
5.2.4.1 REDUCED SUPPLY OF PLASMA DUE TO LOW DONOR TURNOUT
5.2.4.2 STRINGENT GOVERNMENT REGULATIONS
5.3 IMPACT ASSESSMENT OF PLASMA FRACTIONATION MARKET
・ FIGURE 19.... SPECTRUM OF SCENARIOS BASED ON THE IMPACT OF UNCERTAINTIES ON THE GROWTH OF THE PLASMA FRACTIONATION MARKET
5.4 PRICING ANALYSIS
・ TABLE 7........ AVERAGE SELLING PRICE OF PLASMA FRACTIONATION PRODUCTS,
BY KEY PLAYER, 2021 (USD)
・ TABLE 8........ AVERAGE SELLING PRICE OF PLASMA FRACTIONATION PRODUCTS,
BY REGION, 2021 (USD)
5.5 IMPACT OF COVID-19 ON MARKET DYNAMICS
5.5.1 DRIVERS AND OPPORTUNITIES
5.5.2 RESTRAINTS AND CHALLENGES
5.5.3 CUMULATIVE GROWTH ANALYSIS
5.6 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
・ FIGURE 20.............. REVENUE SHIFT & NEW POCKETS FOR PLASMA FRACTIONATION PRODUCT PROVIDERS
5.7 VALUE CHAIN ANALYSIS
・ FIGURE 21.................... PROCEDURE OF PLASMA FRACTIONATION
・ FIGURE 22 VALUE CHAIN ANALYSIS OF THE PLASMA FRACTIONATION MARKET
5.8 SUPPLY CHAIN ANALYSIS
・ FIGURE 23.................... SUPPLY CHAIN ANALYSIS OF THE PLASMA FRACTIONATION MARKET
5.9 ECOSYSTEM ANALYSIS
・ FIGURE 24.. ECOSYSTEM ANALYSIS OF THE PLASMA FRACTIONATION MARKET
・ TABLE 9.......................................... SUPPLY CHAIN ECOSYSTEM
5.10 PATENT ANALYSIS
・ FIGURE 25 PATENT APPLICATIONS FOR THE PLASMA FRACTIONATION MARKET, JANUARY 2012–MARCH 2022
・ TABLE 10.................. INDICATIVE LIST OF PATENTS IN THE PLASMA FRACTIONATION MARKET
5.11 KEY CONFERENCES AND EVENTS IN 2022–2023
・ TABLE 11 PLASMA FRACTIONATION MARKET: LIST OF CONFERENCES AND EVENTS
5.12 REGULATORY ANALYSIS
5.12.1 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS IN DIFFERENT REGIONS/COUNTRIES
5.12.2 REGULATORY SCENARIO IN DIFFERENT REGIONS/COUNTRIES
5.13 PORTER’S FIVE FORCES ANALYSIS
・ TABLE 12 PLASMA FRACTIONATION MARKET: PORTER’S FIVE FORCES ANALYSIS
5.13.1 THREAT FROM NEW ENTRANTS
5.13.2 THREAT FROM SUBSTITUTES
5.13.3 BARGAINING POWER OF BUYERS
5.13.4 BARGAINING POWER OF SUPPLIERS
5.13.5 DEGREE OF COMPETITION
5.14 TECHNOLOGY ANALYSIS
5.14.1 COHN’S COLD ETHANOL PLASMA FRACTIONATION
5.14.2 GEL FILTRATION PLASMA FRACTIONATION
5.14.3 HUMAN PLASMA FRACTIONATION BY POLYETHYLENE GLYCOL
5.14.4 PLASMA FRACTIONATION BY AMMONIUM SULFATE
5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
・ FIGURE 26. INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR
PLASMA FRACTIONATION PRODUCTS
5.16 KEY BUYING CRITERIA BY END USERS
・ FIGURE 27............................... BUYING CRITERIA OF END USERS
6.... PLASMA FRACTIONATION MARKET, BY PRODUCT
6.1 INTRODUCTION
・ TABLE 13............. PLASMA FRACTIONATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
6.2 IMMUNOGLOBULINS
・ TABLE 14.............................................. IVIG VS. SCIG THERAPY
・ TABLE 15.......................... PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY REGION, 2020–2027 (USD MILLION)
・ TABLE 16.. NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 17............. EUROPE: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS,
BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 18....... ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 19.... LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 20 MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 21.......................... PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020–2027 (USD MILLION)
6.2.1 INTRAVENOUS IMMUNOGLOBULINS
6.2.1.1 IVIG HOLDS THE LARGEST SHARE OF THE IMMUNOGLOBULINS MARKET
・ TABLE 22........ INTRAVENOUS IMMUNOGLOBULINS OFFERED BY KEY MARKET PLAYERS
・ TABLE 23...... PLASMA FRACTIONATION MARKET FOR INTRAVENOUS IMMUNOGLOBULINS, BY REGION, 2020–2027 (USD MILLION)
・ TABLE 24.. NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR INTRAVENOUS IMMUNOGLOBULINS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 25............. EUROPE: PLASMA FRACTIONATION MARKET FOR INTRAVENOUS IMMUNOGLOBULINS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 26....... ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR INTRAVENOUS IMMUNOGLOBULINS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 27.... LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR INTRAVENOUS IMMUNOGLOBULINS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 28 MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR INTRAVENOUS IMMUNOGLOBULINS, BY COUNTRY,
2020–2027 (USD MILLION)
6.2.2 SUBCUTANEOUS IMMUNOGLOBULINS
6.2.2.1 BENEFITS OF SELF-ADMINISTRATION AND LOWER INCIDENCE OF NON-SERIOUS SYSTEMIC ADVERSE REACTIONS WILL DRIVE THE GROWTH OF THE SCIG MARKET
・ TABLE 29..... SUBCUTANEOUS IMMUNOGLOBULINS OFFERED BY KEY MARKET PLAYERS
・ TABLE 30... PLASMA FRACTIONATION MARKET FOR SUBCUTANEOUS IMMUNOGLOBULINS, BY REGION, 2020–2027 (USD MILLION)
・ TABLE 31.. NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR SUBCUTANEOUS IMMUNOGLOBULINS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 32............. EUROPE: PLASMA FRACTIONATION MARKET FOR SUBCUTANEOUS IMMUNOGLOBULINS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 33....... ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR SUBCUTANEOUS IMMUNOGLOBULINS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 34.... LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR SUBCUTANEOUS IMMUNOGLOBULINS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 35 MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR SUBCUTANEOUS IMMUNOGLOBULINS, BY COUNTRY,
2020–2027 (USD MILLION)
6.2.3 OTHER IMMUNOGLOBULINS
・ TABLE 36...... OTHER IMMUNOGLOBULINS OFFERED BY KEY MARKET PLAYERS
・ TABLE 37................ PLASMA FRACTIONATION MARKET FOR OTHER IMMUNOGLOBULINS,
BY REGION, 2020–2027 (USD MILLION)
・ TABLE 38.. NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR OTHER IMMUNOGLOBULINS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 39.... EUROPE: PLASMA FRACTIONATION MARKET FOR OTHER IMMUNOGLOBULINS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 40....... ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR OTHER IMMUNOGLOBULINS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 41.... LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR OTHER IMMUNOGLOBULINS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 42 MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR OTHER IMMUNOGLOBULINS, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 COAGULATION FACTOR CONCENTRATES
・ TABLE 43...... PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY REGION, 2020–2027 (USD MILLION)
・ TABLE 44.. NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 45............. EUROPE: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 46....... ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 47.... LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 48 MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY COUNTRY,
2020–2027 (USD MILLION)
・ TABLE 49...... PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020–2027 (USD MILLION)
6.3.1 FACTOR VIII
6.3.1.1 FACTOR VIII HOLDS THE LARGEST SHARE OF THE COAGULATION FACTOR CONCENTRATES MARKET
・ TABLE 50............... FACTOR VIII OFFERED BY KEY MARKET PLAYERS
・ TABLE 51...... PLASMA FRACTIONATION MARKET FOR FACTOR VIII, BY REGION,
2020–2027 (USD MILLION)
・ TABLE 52.. NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR FACTOR VIII,
BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 53... EUROPE: PLASMA FRACTIONATION MARKET FOR FACTOR VIII, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 54....... ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR FACTOR VIII,
BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 55.... LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR FACTOR VIII,
BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 56 MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR FACTOR VIII, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.2 FACTOR IX
6.3.2.1 RISING NUMBER OF HEMOPHILIC PATIENTS TO DRIVE THE GROWTH OF THIS MARKET
・ TABLE 57................. FACTOR IX OFFERED BY KEY MARKET PLAYERS
・ TABLE 58....... PLASMA FRACTIONATION MARKET FOR FACTOR IX, BY REGION,
2020–2027 (USD MILLION)
・ TABLE 59.. NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR FACTOR IX,
BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 60 EUROPE: PLASMA FRACTIONATION MARKET FOR FACTOR IX, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 61....... ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR FACTOR IX,
BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 62.... LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR FACTOR IX,
BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 63 MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR FACTOR IX, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.3 VON WILLEBRAND FACTOR
6.3.3.1 MARKET GROWTH IS PRIMARILY DRIVEN BY THE INCREASING PREVALENCE AND DIAGNOSIS OF VON WILLEBRAND DISEASE AND HEMOPHILIA
・ TABLE 64........ VON WILLEBRAND FACTOR OFFERED BY KEY MARKET PLAYERS
・ TABLE 65.. PLASMA FRACTIONATION MARKET FOR VON WILLEBRAND FACTOR, BY REGION, 2020–2027 (USD MILLION)
・ TABLE 66.. NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR VON WILLEBRAND FACTOR, BY COUNTRY, 2020–2027 (USD MILLION). 107
・ TABLE 67....... EUROPE: PLASMA FRACTIONATION MARKET FOR VON WILLEBRAND FACTOR, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 68. ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR VON WILLEBRAND FACTOR, BY COUNTRY, 2020–2027 (USD MILLION). 108
・ TABLE 69.... LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR VON WILLEBRAND FACTOR, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 70 MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR VON WILLEBRAND FACTOR, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.4 PROTHROMBIN COMPLEX CONCENTRATES
6.3.4.1 ADVANTAGES OF PCC OVER FRESH FROZEN PLASMA WILL SUPPORT MARKET GROWTH IN THIS SEGMENT
・ TABLE 71 PROTHROMBIN COMPLEX CONCENTRATES OFFERED BY KEY MARKET PLAYERS
・ TABLE 72..... PLASMA FRACTIONATION MARKET FOR PROTHROMBIN COMPLEX CONCENTRATES, BY REGION, 2020–2027 (USD MILLION)
・ TABLE 73.. NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR PROTHROMBIN COMPLEX CONCENTRATES, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 74............. EUROPE: PLASMA FRACTIONATION MARKET FOR PROTHROMBIN COMPLEX CONCENTRATES, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 75....... ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR PROTHROMBIN COMPLEX CONCENTRATES, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 76.... LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR PROTHROMBIN COMPLEX CONCENTRATES, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 77 MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR PROTHROMBIN COMPLEX CONCENTRATES, BY COUNTRY,
2020–2027 (USD MILLION)
6.3.5 FIBRINOGEN CONCENTRATES
6.3.5.1 SAFETY PROFILE, ACCURACY, AND SPEED OF ADMINISTRATION ARE THE KEY ADVANTAGES OF FIBRINOGEN CONCENTRATES
・ TABLE 78.... FIBRINOGEN CONCENTRATES OFFERED BY KEY MARKET PLAYERS
・ TABLE 79......... PLASMA FRACTIONATION MARKET FOR FIBRINOGEN CONCENTRATES,
BY REGION, 2020–2027 (USD MILLION)
・ TABLE 80.. NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR FIBRINOGEN CONCENTRATES, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 81............. EUROPE: PLASMA FRACTIONATION MARKET FOR FIBRINOGEN CONCENTRATES, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 82....... ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR FIBRINOGEN CONCENTRATES, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 83.... LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR FIBRINOGEN CONCENTRATES, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 84 MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR FIBRINOGEN CONCENTRATES, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.6 FACTOR XIII
6.3.6.1 APPLICATIONS IN TREATING RARE BLEEDING DISORDERS WILL CONTRIBUTE TO THE DEMAND FOR FACTOR XIII
・ TABLE 85............... FACTOR XIII OFFERED BY KEY MARKET PLAYERS
・ TABLE 86...... PLASMA FRACTIONATION MARKET FOR FACTOR XIII, BY REGION,
2020–2027 (USD MILLION)
・ TABLE 87.. NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR FACTOR XIII,
BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 88... EUROPE: PLASMA FRACTIONATION MARKET FOR FACTOR XIII, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 89....... ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR FACTOR XIII,
BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 90.... LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR FACTOR XIII,
BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 91 MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR FACTOR XIII, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.7 FACTOR XI
6.3.7.1 GROWING DEMAND FOR FACTOR XI TO TREAT BLEEDING DISORDERS IN PATIENTS TO DRIVE GROWTH
・ TABLE 92....... PLASMA FRACTIONATION MARKET FOR FACTOR XI, BY REGION,
2020–2027 (USD MILLION)
・ TABLE 93.. NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR FACTOR XI,
BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 94 EUROPE: PLASMA FRACTIONATION MARKET FOR FACTOR XI, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 95....... ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR FACTOR XI,
BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 96.... LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR FACTOR XI,
BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 97 MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR FACTOR XI, BY COUNTRY, 2020–2027 (USD MILLION)
6.4 ALBUMIN
6.4.1 RISING DEMAND FOR ALBUMIN AS AN ANTIOXIDANT TO DRIVE MARKET GROWTH
・ TABLE 98.................. ALBUMIN OFFERED BY KEY MARKET PLAYERS
・ TABLE 99........ PLASMA FRACTIONATION MARKET FOR ALBUMIN, BY REGION,
2020–2027 (USD MILLION)
・ TABLE 100. NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR ALBUMIN,
BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 101............ EUROPE: PLASMA FRACTIONATION MARKET FOR ALBUMIN, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 102..... ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR ALBUMIN,
BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 103.. LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR ALBUMIN,
BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 104......... MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR ALBUMIN, BY COUNTRY, 2020–2027 (USD MILLION)
6.5 PROTEASE INHIBITORS
6.5.1 RISING PREVALENCE OF COPD WILL DRIVE THE DEMAND FOR
PROTEASE INHIBITORS
・ TABLE 105........... PROTEASE INHIBITORS OFFERED BY KEY MARKET PLAYERS
・ TABLE 106.......... PLASMA FRACTIONATION MARKET FOR PROTEASE INHIBITORS, BY REGION, 2020–2027 (USD MILLION)
・ TABLE 107. NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR PROTEASE INHIBITORS, BY COUNTRY, 2020–2027 (USD MILLION). 123
・ TABLE 108............ EUROPE: PLASMA FRACTIONATION MARKET FOR PROTEASE INHIBITORS,
BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 109..... ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR PROTEASE INHIBITORS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 110.. LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR PROTEASE INHIBITORS, BY COUNTRY, 2020–2027 (USD MILLION). 124
・ TABLE 111......... MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR PROTEASE INHIBITORS, BY COUNTRY, 2020–2027 (USD MILLION)
6.6 OTHER PLASMA PRODUCTS
・ TABLE 112... PLASMA FRACTIONATION MARKET FOR OTHER PLASMA PRODUCTS,
BY REGION, 2020–2027 (USD MILLION)
・ TABLE 113. NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR OTHER PLASMA PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 114.. EUROPE: PLASMA FRACTIONATION MARKET FOR OTHER PLASMA PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 115..... ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR OTHER PLASMA PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 116.. LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR OTHER PLASMA PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 117......... MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR OTHER PLASMA PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)
7.... PLASMA FRACTIONATION MARKET, BY APPLICATION
7.1 INTRODUCTION
・ TABLE 118...... PLASMA FRACTIONATION MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
7.2 NEUROLOGY
7.2.1 RISING PREVALENCE OF MAJOR AGE-RELATED NEUROLOGICAL DISORDERS TO DRIVE MARKET GROWTH
・ TABLE 119 NUMBER OF DALYS FOR NEUROLOGICAL DISORDERS AND THE PERCENTAGE OF DALYS PROJECTED FOR 2005, 2015, AND 2030.. 130
・ TABLE 120. PLASMA-DERIVED PRODUCTS AND THEIR APPLICATIONS IN NEUROLOGY
・ TABLE 121....... PLASMA FRACTIONATION MARKET FOR NEUROLOGY APPLICATIONS,
BY REGION, 2020–2027 (USD MILLION)
・ TABLE 122. NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR NEUROLOGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 123............ EUROPE: PLASMA FRACTIONATION MARKET FOR NEUROLOGY APPLICATIONS, 2020–2027 (USD MILLION)
・ TABLE 124..... ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR NEUROLOGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 125.. LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR NEUROLOGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 126......... MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR NEUROLOGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 IMMUNOLOGY
7.3.1 INCREASING PREVALENCE OF IMMUNODEFICIENCY DISORDERS AMONG CHILDREN AND ADULTS WILL DRIVE THE GROWTH OF THIS MARKET
・ TABLE 127................... LIST OF FDA-APPROVED INDICATIONS FOR IMMUNOGLOBULINS IN IMMUNOLOGY
・ TABLE 128 DIAGNOSIS DISTRIBUTION OF DIFFERENT CATEGORIES OF PRIMARY IMMUNODEFICIENCY DISEASE
・ TABLE 129 PREVALENCE OF PRIMARY IMMUNODEFICIENCY DISEASE, BY REGION,
2013 VS. 2015
・ TABLE 130. PLASMA-DERIVED PRODUCTS AND THEIR APPLICATIONS IN IMMUNOLOGY
・ TABLE 131..... PLASMA FRACTIONATION MARKET FOR IMMUNOLOGY APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
・ TABLE 132. NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR IMMUNOLOGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 133............ EUROPE: PLASMA FRACTIONATION MARKET FOR IMMUNOLOGY APPLICATIONS, 2020–2027 (USD MILLION)
・ TABLE 134..... ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR IMMUNOLOGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 135.. LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR IMMUNOLOGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 136......... MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR IMMUNOLOGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
7.4 HEMATOLOGY
7.4.1 GROWTH IN THE NUMBER OF HEMOPHILIA PATIENTS TO DRIVE THE DEMAND FOR COAGULATION FACTOR CONCENTRATES AND IMMUNOGLOBULINS
・ TABLE 137......... NUMBER OF HEMOPHILIA PATIENTS (2012–2020)
・ TABLE 138. PLASMA-DERIVED PRODUCTS AND THEIR APPLICATIONS IN HEMATOLOGY
・ TABLE 139..... PLASMA FRACTIONATION MARKET FOR HEMATOLOGY APPLICATIONS,
BY REGION, 2020–2027 (USD MILLION)
・ TABLE 140. NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR HEMATOLOGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 141............ EUROPE: PLASMA FRACTIONATION MARKET FOR HEMATOLOGY APPLICATIONS, 2020–2027 (USD MILLION)
・ TABLE 142..... ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR HEMATOLOGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 143.. LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR HEMATOLOGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 144......... MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR HEMATOLOGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
7.5 CRITICAL CARE
7.5.1 INCREASING OFF-LABEL USE OF ALBUMIN AND RISING USE OF ANTICOAGULANTS TO DRIVE THE DEMAND FOR PLASMA-DERIVED CRITICAL CARE PRODUCTS
・ TABLE 145. PLASMA-DERIVED PRODUCTS AND THEIR APPLICATIONS IN CRITICAL CARE
・ TABLE 146.... PLASMA FRACTIONATION MARKET FOR CRITICAL CARE APPLICATIONS,
BY REGION, 2020–2027 (USD MILLION)
・ TABLE 147. NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR CRITICAL CARE APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 148 EUROPE: PLASMA FRACTIONATION MARKET FOR CRITICAL CARE APPLICATIONS, 2020–2027 (USD MILLION)
・ TABLE 149..... ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR CRITICAL CARE APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 150.. LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR CRITICAL CARE APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 151......... MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR CRITICAL CARE APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
7.6 PULMONOLOGY
7.6.1 RISING PREVALENCE OF ALPHA-1-ANTITRYPSIN DEFICIENCY AND COPD TO DRIVE THE PLASMA FRACTIONATION MARKET FOR PULMONOLOGY
・ TABLE 152. PLASMA-DERIVED PRODUCTS AND THEIR APPLICATIONS IN PULMONOLOGY
・ TABLE 153... PLASMA FRACTIONATION MARKET FOR PULMONOLOGY APPLICATIONS,
BY REGION, 2020–2027 (USD MILLION)
・ TABLE 154. NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR PULMONOLOGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 155............ EUROPE: PLASMA FRACTIONATION MARKET FOR PULMONOLOGY APPLICATIONS, 2020–2027 (USD MILLION)
・ TABLE 156..... ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR PULMONOLOGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 157.. LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR PULMONOLOGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 158......... MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR PULMONOLOGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
7.7 HEMATO-ONCOLOGY
7.7.1 RISING NUMBER OF BLOOD CANCER PATIENTS TO DRIVE THE DEMAND FOR PLASMA-DERIVED PRODUCTS
・ TABLE 159...... INCIDENCE OF LEUKEMIA, MULTIPLE MYELOMA, AND HODGKIN’S LYMPHOMA, BY REGION, 2012−2018
・ TABLE 160. PLASMA-DERIVED PRODUCTS AND THEIR APPLICATIONS IN HEMATO-ONCOLOGY
・ TABLE 161........... PLASMA FRACTIONATION MARKET FOR HEMATO-ONCOLOGY APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
・ TABLE 162. NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR HEMATO-ONCOLOGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 163 EUROPE: PLASMA FRACTIONATION MARKET FOR HEMATO-ONCOLOGY APPLICATIONS, 2020–2027 (USD MILLION)
・ TABLE 164..... ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR HEMATO-ONCOLOGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 165.. LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR HEMATO-ONCOLOGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 166......... MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR HEMATO-ONCOLOGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
7.8 RHEUMATOLOGY
7.8.1 INCREASING PREVALENCE OF RHEUMATIC CONDITIONS TO DRIVE THE PLASMA FRACTIONATION MARKET FOR RHEUMATOLOGY
・ TABLE 167.. PLASMA FRACTIONATION MARKET FOR RHEUMATOLOGY APPLICATIONS,
BY REGION, 2020–2027 (USD MILLION)
・ TABLE 168. NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR RHEUMATOLOGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 169............ EUROPE: PLASMA FRACTIONATION MARKET FOR RHEUMATOLOGY APPLICATIONS, 2020–2027 (USD MILLION)
・ TABLE 170..... ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR RHEUMATOLOGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 171.. LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR RHEUMATOLOGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 172......... MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR RHEUMATOLOGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
7.9 OTHER APPLICATIONS
・ TABLE 173 PLASMA-DERIVED PRODUCTS FOR OTHER APPLICATIONS
・ TABLE 174............... PLASMA FRACTIONATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
・ TABLE 175. NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION). 154
・ TABLE 176.. EUROPE: PLASMA FRACTIONATION MARKET FOR OTHER APPLICATIONS, 2020–2027 (USD MILLION)
・ TABLE 177..... ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 178.. LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION). 155
・ TABLE 179......... MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
8.... PLASMA FRACTIONATION MARKET, BY END USER
8.1 INTRODUCTION
・ TABLE 180. PLASMA FRACTIONATION MARKET, BY END USER, 2020–2027 (USD MILLION)
8.2 HOSPITALS & CLINICS
8.2.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND GROWING NUMBER OF HOSPITALS & CLINICS—KEY FACTORS DRIVING GROWTH
・ TABLE 181...... PLASMA FRACTIONATION MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020–2027 (USD MILLION)
・ TABLE 182. NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 183............ EUROPE: PLASMA FRACTIONATION MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 184..... ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 185.. LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR HOSPITALS & CLINICS, 2020–2027 (USD MILLION)
・ TABLE 186......... MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 CLINICAL RESEARCH LABORATORIES
8.3.1 INCREASING NUMBER OF CLINICAL STUDIES ON NEW THERAPEUTIC INDICATIONS FOR PLASMA-DERIVED PRODUCTS TO DRIVE MARKET GROWTH
・ TABLE 187........... PLASMA FRACTIONATION MARKET FOR CLINICAL RESEARCH LABORATORIES, BY REGION, 2020–2027 (USD MILLION)
・ TABLE 188. NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR CLINICAL RESEARCH LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 189 EUROPE: PLASMA FRACTIONATION MARKET FOR CLINICAL RESEARCH LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 190..... ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR CLINICAL RESEARCH LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 191.. LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR CLINICAL RESEARCH LABORATORIES, 2020–2027 (USD MILLION). 162
・ TABLE 192......... MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR CLINICAL RESEARCH LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)
8.4 ACADEMIC INSTITUTES
8.4.1 GROWING DEMAND FOR NEW DRUG MOLECULES TO DRIVE THE DEMAND FOR PLASMA PRODUCTS IN ACADEMIC INSTITUTES
・ TABLE 193......... PLASMA FRACTIONATION MARKET FOR ACADEMIC INSTITUTES, BY REGION, 2020–2027 (USD MILLION)
・ TABLE 194. NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION). 164
・ TABLE 195............ EUROPE: PLASMA FRACTIONATION MARKET FOR ACADEMIC INSTITUTES, 2020–2027 (USD MILLION)
・ TABLE 196..... ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 197.. LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR ACADEMIC INSTITUTES BY COUNTRY, 2020–2027 (USD MILLION). 165
・ TABLE 198......... MIDDLE EAST & AFRICA: PLASMA FRACTIONATION MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
9.... PLASMA FRACTIONATION MARKET, BY REGION
9.1 INTRODUCTION
・ TABLE 199.... PLASMA FRACTIONATION MARKET, BY REGION, 2020–2027 (USD MILLION)
9.2 NORTH AMERICA
・ FIGURE 28...... NORTH AMERICA: PLASMA FRACTIONATION MARKET SNAPSHOT
・ TABLE 200.. NORTH AMERICA: PLASMA FRACTIONATION MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・ TABLE 201.. NORTH AMERICA: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・ TABLE 202. NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 203. NORTH AMERICA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 204.. NORTH AMERICA: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 205.. NORTH AMERICA: PLASMA FRACTIONATION MARKET, BY END USER,
2020–2027 (USD MILLION)
9.2.1 US
9.2.1.1 THE US IS THE LARGEST MARKET FOR PLASMA FRACTIONATION PRODUCTS
・ TABLE 206...... US: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・ TABLE 207................... US: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 208 US: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 209. US: PLASMA FRACTIONATION MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 210..... US: PLASMA FRACTIONATION MARKET, BY END USER,
2020–2027 (USD MILLION)
9.2.2 CANADA
9.2.2.1 CANADA IS ONE OF THE WORLD’S HIGHEST PER CAPITA USERS OF IVIG—
A KEY FACTOR DRIVING MARKET GROWTH
・ TABLE 211............. CANADA: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・ TABLE 212........... CANADA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS,
BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 213........... CANADA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 214............. CANADA: PLASMA FRACTIONATION MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 215....... CANADA: PLASMA FRACTIONATION MARKET, BY END USER,
2020–2027 (USD MILLION)
9.3 EUROPE
・ TABLE 216 EUROPE: PLASMA FRACTIONATION MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・ TABLE 217 EUROPE: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・ TABLE 218............ EUROPE: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS,
BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 219............ EUROPE: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 220............. EUROPE: PLASMA FRACTIONATION MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 221....... EUROPE: PLASMA FRACTIONATION MARKET, BY END USER,
2020–2027 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 GERMANY HAS THE HIGHEST PLASMA FRACTIONATION CAPACITY IN EUROPE
・ TABLE 222........... GERMANY: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・ TABLE 223......... GERMANY: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS,
BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 224......... GERMANY: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 225........... GERMANY: PLASMA FRACTIONATION MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 226..... GERMANY: PLASMA FRACTIONATION MARKET, BY END USER,
2020–2027 (USD MILLION)
9.3.2 UK
9.3.2.1 INCREASING INCIDENCE OF HEMOPHILIA AND THE GROWING CONSUMPTION OF COAGULATION FACTORS TO DRIVE MARKET GROWTH IN THE UK
・ TABLE 227...... UK: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・ TABLE 228................... UK: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 229 UK: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 230. UK: PLASMA FRACTIONATION MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 231..... UK: PLASMA FRACTIONATION MARKET, BY END USER,
2020–2027 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 HIGH PREVALENCE OF BLEEDING DISORDERS TO DRIVE THE MARKET FOR PLASMA FRACTIONATION IN FRANCE
・ TABLE 232....... NUMBER OF PEOPLE WITH BLEEDING DISORDERS IN FRANCE, 2012–2020
・ TABLE 233 FRANCE: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・ TABLE 234............ FRANCE: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 235............ FRANCE: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 236............. FRANCE: PLASMA FRACTIONATION MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 237....... FRANCE: PLASMA FRACTIONATION MARKET, BY END USER,
2020–2027 (USD MILLION)
9.3.4 ITALY
9.3.4.1 GROWTH IN THE COUNTRY’S GERIATRIC POPULATION DRIVES THE MARKET FOR PLASMA FRACTIONATION
・ TABLE 238...... PRODUCTION OF PLASMA PRODUCTS IN ITALY (2013, 2018, AND 2023-E)
・ TABLE 239... ITALY: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・ TABLE 240................ ITALY: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 241................ ITALY: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 242................. ITALY: PLASMA FRACTIONATION MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 243.. ITALY: PLASMA FRACTIONATION MARKET, BY END USER,
2020–2027 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 GROWING DEMAND FOR PLASMA PRODUCTS FOR THE TREATMENT OF CHRONIC DISEASES IN THE ELDERLY IS THE KEY FACTOR DRIVING MARKET GROWTH
・ TABLE 244. SPAIN: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・ TABLE 245.............. SPAIN: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 246.............. SPAIN: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 247................ SPAIN: PLASMA FRACTIONATION MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 248. SPAIN: PLASMA FRACTIONATION MARKET, BY END USER,
2020–2027 (USD MILLION)
9.3.6 REST OF EUROPE
・ TABLE 249.. ROE: NUMBER OF HEMOPHILIA PATIENTS, BY COUNTRY, 2012–2018
・ TABLE 250.... ROE: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・ TABLE 251................. ROE: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 252................. ROE: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 253 ROE: PLASMA FRACTIONATION MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 254.... ROE: PLASMA FRACTIONATION MARKET, BY END USER,
2020–2027 (USD MILLION)
9.4 ASIA PACIFIC
・ FIGURE 29...... APAC: PLASMA FRACTIONATION MARKET SNAPSHOT
・ TABLE 255....... ASIA PACIFIC: PLASMA FRACTIONATION MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・ TABLE 256....... ASIA PACIFIC: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・ TABLE 257..... ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 258..... ASIA PACIFIC: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 259....... ASIA PACIFIC: PLASMA FRACTIONATION MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 260. ASIA PACIFIC: PLASMA FRACTIONATION MARKET, BY END USER,
2020–2027 (USD MILLION)
9.4.1 CHINA
9.4.1.1 RISING INCIDENCE OF DISEASES SUCH AS LIVER CANCER AND HEPATITIS B TO DRIVE MARKET GROWTH IN CHINA
・ TABLE 261. CHINA: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・ TABLE 262.............. CHINA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS,
BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 263.............. CHINA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 264............... CHINA: PLASMA FRACTIONATION MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 265. CHINA: PLASMA FRACTIONATION MARKET, BY END USER,
2020–2027 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 RISING PREVALENCE OF NEUROLOGICAL DISORDERS AND HEMATOLOGICAL DISEASES WILL SUPPORT MARKET GROWTH IN THE COUNTRY
・ TABLE 266...... MEAN PER CAPITA FACTOR VIII AND IX USE IN JAPAN,
2014 VS. 2018 (IN IU/TOTAL POPULATION)
・ TABLE 267... PATIENTS WITH BLEEDING DISORDERS IN JAPAN, 2014 VS. 2020
・ TABLE 268. JAPAN: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・ TABLE 269.............. JAPAN: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS,
BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 270.............. JAPAN: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 271............... JAPAN: PLASMA FRACTIONATION MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 272. JAPAN: PLASMA FRACTIONATION MARKET, BY END USER,
2020–2027 (USD MILLION)
9.4.3 AUSTRALIA
9.4.3.1 GROWING DEMAND FOR PLASMA PRODUCTS FOR THE TREATMENT OF CHRONIC DISEASES TO DRIVE MARKET GROWTH
・ TABLE 273........ TOTAL IG (GRAMS) USED IN AUSTRALIA, 2008/09–2017/18
・ TABLE 274 AUSTRALIAN GOVERNMENT FUNDING FOR THE SUPPLY OF BLOOD AND BLOOD PRODUCTS, 2008–2018 (USD MILLION)
・ TABLE 275..... AUSTRALIA: BLOOD SECTOR OVERVIEW (2017–2018)
・ TABLE 276......... AUSTRALIA: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・ TABLE 277........ AUSTRALIA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS,
BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 278........ AUSTRALIA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 279......... AUSTRALIA: PLASMA FRACTIONATION MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 280... AUSTRALIA: PLASMA FRACTIONATION MARKET, BY END USER,
2020–2027 (USD MILLION)
9.4.4 INDIA
9.4.4.1 GROWING HEALTHCARE AWARENESS, AVAILABILITY OF BETTER DIAGNOSTIC TOOLS, AND THE RISING GERIATRIC POPULATION TO DRIVE MARKET GROWTH
・ TABLE 281............... INDIA: NUMBER OF PATIENTS WITH BLEEDING DISORDERS, 2012–2018
・ TABLE 282.. INDIA: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・ TABLE 283............... INDIA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 284............... INDIA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 285................ INDIA: PLASMA FRACTIONATION MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 286.. INDIA: PLASMA FRACTIONATION MARKET, BY END USER,
2020–2027 (USD MILLION)
9.4.5 VIETNAM
9.4.5.1 GROWING POOL OF PATIENTS SUFFERING FROM COPD, PID, AND BLEEDING DISORDERS TO DRIVE MARKET GROWTH
・ TABLE 287............ VIETNAM: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・ TABLE 288........... VIETNAM: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS,
BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 289........... VIETNAM: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 290............ VIETNAM: PLASMA FRACTIONATION MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 291...... VIETNAM: PLASMA FRACTIONATION MARKET, BY END USER,
2020–2027 (USD MILLION)
9.4.6 INDONESIA
9.4.6.1 GROWING GOVERNMENT INITIATIVES TO DRIVE MARKET GROWTH
・ TABLE 292......... INDONESIA: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・ TABLE 293........ INDONESIA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS,
BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 294........ INDONESIA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 295......... INDONESIA: PLASMA FRACTIONATION MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 296... INDONESIA: PLASMA FRACTIONATION MARKET, BY END USER,
2020–2027 (USD MILLION)
9.4.7 MALAYSIA
9.4.7.1 INCREASING PREVALENCE OF BLEEDING DISORDERS WILL SUPPORT THE PLASMA FRACTIONATION MARKET IN MALAYSIA
・ TABLE 297.......... MALAYSIA: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・ TABLE 298......... MALAYSIA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS,
BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 299......... MALAYSIA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 300.......... MALAYSIA: PLASMA FRACTIONATION MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 301.... MALAYSIA: PLASMA FRACTIONATION MARKET, BY END USER,
2020–2027 (USD MILLION)
9.4.8 REST OF ASIA PACIFIC
・ TABLE 302............. ROAPAC: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・ TABLE 303........... ROAPAC: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS,
BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 304........... ROAPAC: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 305............. ROAPAC: PLASMA FRACTIONATION MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 306....... ROAPAC: PLASMA FRACTIONATION MARKET, BY END USER,
2020–2027 (USD MILLION)
9.5 LATIN AMERICA
・ TABLE 307.... LATIN AMERICA: PLASMA FRACTIONATION MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・ TABLE 308.... LATIN AMERICA: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・ TABLE 309.. LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 310.. LATIN AMERICA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 311.... LATIN AMERICA: PLASMA FRACTIONATION MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 312.... LATIN AMERICA: PLASMA FRACTIONATION MARKET, BY END USER,
2020–2027 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 GROWTH OF VACCINE MANUFACTURING TO INCREASE THE MARKET GROWTH
・ TABLE 313 BRAZIL: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・ TABLE 314............. BRAZIL: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS,
BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 315............. BRAZIL: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 316.............. BRAZIL: PLASMA FRACTIONATION MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 317 BRAZIL: PLASMA FRACTIONATION MARKET, BY END USER,
2020–2027 (USD MILLION)
9.5.2 ROLATAM
・ TABLE 318........... ROLATAM: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・ TABLE 319.......... ROLATAM: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS,
BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 320.......... ROLATAM: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 321........... ROLATAM: PLASMA FRACTIONATION MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 322..... ROLATAM: PLASMA FRACTIONATION MARKET, BY END USER,
2020–2027 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
・ TABLE 323 HEMOPHILIA PATIENTS IN THE MIDDLE EAST & AFRICA, BY COUNTRY,
2012–2020
・ TABLE 324........ PER CAPITA CONSUMPTION OF FACTORS IX AND VIII (IU/TOTAL POPULATION) IN SOUTH AFRICA, SAUDI ARABIA, AND IRAQ, 2012–2018
・ TABLE 325.... MEA: PLASMA FRACTIONATION MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・ TABLE 326.... MEA: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・ TABLE 327................ MEA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 328................ MEA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 329 MEA: PLASMA FRACTIONATION MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 330... MEA: PLASMA FRACTIONATION MARKET, BY END USER,
2020–2027 (USD MILLION)
9.6.1 TURKEY
9.6.1.1 TURKEY DOMINATES THE PLASMA FRACTIONATION MARKET IN THE MIDDLE EAST & AFRICA
・ TABLE 331.......................... TURKEY: DEMOGRAPHIC INDICATORS
・ TABLE 332 TURKEY: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・ TABLE 333............ TURKEY: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS,
BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 334............ TURKEY: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 335.............. TURKEY: PLASMA FRACTIONATION MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 336 TURKEY: PLASMA FRACTIONATION MARKET, BY END USER,
2020–2027 (USD MILLION)
9.6.2 SAUDI ARABIA
9.6.2.1 DEVELOPMENTS IN HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
・ TABLE 337..... SAUDI ARABIA: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・ TABLE 338.... SAUDI ARABIA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 339.... SAUDI ARABIA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 340..... SAUDI ARABIA: PLASMA FRACTIONATION MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 341 SAUDI ARABIA: PLASMA FRACTIONATION MARKET, BY END USER,
2020–2027 (USD MILLION)
9.6.3 EGYPT
9.6.3.1 GROWING RESEARCH ON PLASMA AND PLASMA DERIVATIVES WILL SUPPORT MARKET GROWTH
・ TABLE 342. EGYPT: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・ TABLE 343.............. EGYPT: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS,
BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 344.............. EGYPT: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 345................ EGYPT: PLASMA FRACTIONATION MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 346. EGYPT: PLASMA FRACTIONATION MARKET, BY END USER,
2020–2027 (USD MILLION)
9.6.4 UAE
9.6.4.1 GROWING GOVERNMENT INITIATIVES FOR HEALTHCARE INFRASTRUCTURE DEVELOPMENT TO DRIVE MARKET GROWTH IN THE UAE
・ TABLE 347.... UAE: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・ TABLE 348................. UAE: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 349................. UAE: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 350 UAE: PLASMA FRACTIONATION MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 351.... UAE: PLASMA FRACTIONATION MARKET, BY END USER,
2020–2027 (USD MILLION)
9.6.5 REST OF THE MIDDLE EAST & AFRICA
・ TABLE 352.... HEMOPHILIA PATIENTS IN THE REST OF MIDDLE EAST & AFRICA, 2012−2018
・ TABLE 353 ROMEA: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・ TABLE 354............. ROMEA: PLASMA FRACTIONATION MARKET FOR IMMUNOGLOBULINS,
BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 355............. ROMEA: PLASMA FRACTIONATION MARKET FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2020–2027 (USD MILLION)
・ TABLE 356.............. ROMEA: PLASMA FRACTIONATION MARKET, BY APPLICATION,
2020–2027 (USD MILLION)
・ TABLE 357 ROMEA: PLASMA FRACTIONATION MARKET, BY END USER,
2020–2027 (USD MILLION)
10.. COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
・ FIGURE 30 KEY PLAYER STRATEGIES IN THE PLASMA FRACTIONATION MARKET,
2018–2022
10.3 MARKET SHARE ANALYSIS
・ FIGURE 31........ PLASMA FRACTIONATION MARKET: MARKET SHARE ANALYSIS,
2021 (TOP 5 PLAYERS)
・ TABLE 358.............. PLASMA FRACTIONATION MARKET: DEGREE OF COMPETITION
10.4 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
・ FIGURE 32.. REVENUE SHARE ANALYSIS OF PLAYERS IN THE PLASMA FRACTIONATION MARKET (TOP 5)
10.5 COMPANY EVALUATION QUADRANT
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
・ FIGURE 33............... PLASMA FRACTIONATION MARKET: COMPANY EVALUATION QUADRANT, 2021
10.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES
10.6.1 PROGRESSIVE COMPANIES
10.6.2 STARTING BLOCKS
10.6.3 RESPONSIVE COMPANIES
10.6.4 DYNAMIC COMPANIES
・ FIGURE 34............... PLASMA FRACTIONATION MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2021
10.7 COMPETITIVE BENCHMARKING
10.7.1 COMPANY PRODUCT & REGIONAL FOOTPRINT (25 COMPANIES)
・ FIGURE 35...... PRODUCT & REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS IN THE PLASMA FRACTIONATION MARKET
10.7.2 COMPANY PRODUCT FOOTPRINT (25 COMPANIES)
・ TABLE 359.................... PRODUCT PORTFOLIO ANALYSIS: PLASMA FRACTIONATION MARKET (2021)
10.7.3 COMPANY REGIONAL FOOTPRINT (25 COMPANIES)
・ TABLE 360........ REGIONAL REVENUE MIX: PLASMA FRACTIONATION MARKET (2021)
10.8 COMPETITIVE SCENARIO AND TRENDS
・ TABLE 361..... PRODUCT LAUNCHES & APPROVALS, JANUARY 2018–APRIL 2022
・ TABLE 362........................... DEALS, JANUARY 2018–APRIL 2022
・ TABLE 363..... OTHER DEVELOPMENTS, JANUARY 2018–APRIL 2022
10.9 COMPETITIVE BENCHMARKING
・ TABLE 364. PLASMA FRACTIONATION MARKET: DETAILED LIST OF KEY START-UPS/SMES
・ TABLE 365........... PLASMA FRACTIONATION MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS [START-UPS/SMES]
11.. COMPANY PROFILES
11.1 KEY PLAYERS
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW)*
11.1.1 CSL
・ TABLE 366........................................ CSL: BUSINESS OVERVIEW
・ FIGURE 36............................. CSL: COMPANY SNAPSHOT (2021)
11.1.2 GRIFOLS, S.A.
・ TABLE 367........................... GRIFOLS, S.A.: BUSINESS OVERVIEW
・ FIGURE 37................ GRIFOLS, S.A.: COMPANY SNAPSHOT (2021)
11.1.3 SHIRE (TAKEDA PHARMACEUTICAL COMPANY LIMITED)
・ TABLE 368..................................... SHIRE: BUSINESS OVERVIEW
・ FIGURE 38 TAKEDA PHARMACEUTICAL COMPANY LIMITED: COMPANY SNAPSHOT (2021)
11.1.4 OCTAPHARMA AG
・ TABLE 369...................... OCTAPHARMA AG: BUSINESS OVERVIEW
・ FIGURE 39............ OCTAPHARMA AG: COMPANY SNAPSHOT (2021)
11.1.5 KEDRION S.P.A
・ TABLE 370......................... KEDRION S.P.A: BUSINESS OVERVIEW
・ FIGURE 40............... KEDRION S.P.A: COMPANY SNAPSHOT (2020)
11.1.6 LFB
・ TABLE 371........................................ LFB: BUSINESS OVERVIEW
11.1.7 BIOTEST AG
・ TABLE 372.............................. BIOTEST AG: BUSINESS OVERVIEW
・ FIGURE 41................... BIOTEST AG: COMPANY SNAPSHOT (2021)
11.1.8 SANQUIN
・ TABLE 373................................. SANQUIN: BUSINESS OVERVIEW
・ FIGURE 42...................... SANQUIN: COMPANY SNAPSHOT (2021)
11.1.9 CHINA BIOLOGIC PRODUCTS HOLDINGS, INC.
・ TABLE 374. CHINA BIOLOGIC PRODUCTS HOLDINGS, INC.: BUSINESS OVERVIEW
11.1.10 GC PHARMA
・ TABLE 375............................. GC PHARMA: BUSINESS OVERVIEW
・ FIGURE 43.................. GC PHARMA: COMPANY SNAPSHOT (2020)
11.1.11 BIO PRODUCTS LABORATORY LTD. 297
・ TABLE 376. BIO PRODUCTS LABORATORY LTD.: BUSINESS OVERVIEW
11.1.12 JAPAN BLOOD PRODUCTS ORGANIZATION
・ TABLE 377..... JAPAN BLOOD PRODUCTS ORGANIZATION: BUSINESS OVERVIEW
・ FIGURE 44..... JAPAN BLOOD PRODUCTS ORGANIZATION: COMPANY SNAPSHOT (2020)
11.1.13 EMERGENT BIOSOLUTIONS
・ TABLE 378.......... EMERGENT BIOSOLUTIONS: BUSINESS OVERVIEW
・ FIGURE 45 EMERGENT BIOSOLUTIONS: COMPANY SNAPSHOT (2021)
11.1.14 SHANGHAI RAAS BLOOD PRODUCTS CO., LTD.
・ TABLE 379 SHANGHAI RAAS BLOOD PRODUCTS CO., LTD.: BUSINESS OVERVIEW
11.1.15 INTAS PHARMACEUTICALS LTD. 309
・ TABLE 380.... INTAS PHARMACEUTICALS LTD.: BUSINESS OVERVIEW
・ FIGURE 46.... INTAS PHARMACEUTICALS LTD.: COMPANY SNAPSHOT (2021)
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
11.2 OTHER COMPANIES
11.2.1 BHARAT SERUMS AND VACCINES LIMITED
11.2.2 SK PLASMA
11.2.3 SICHUAN YUANDA SHUYANG PHARMACEUTICAL CO., LTD.
11.2.4 KABAFUSION
11.2.5 CENTURION PHARMA.. 315
11.2.6 ADMA BIOLOGICS, INC.
11.2.7 PLASMAGEN BIOSCIENCES PVT. LTD.
11.2.8 VIRCHOW BIOTECH PRIVATE LIMITED
11.2.9 FUSION HEALTHCARE. 317
11.2.10 HEMARUS THERAPEUTICS LIMITED.. 318
12.. APPENDIX